← Back to Search

Wake (non-nap) for Sleep Deprivation

N/A

Recruiting

Research Sponsored by University of Massachusetts, Amherst

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Infants must be 9 months at the time of enrollment

Infants must have normal birthweight (5.5 to 10 lbs) and gestational length (36-41 weeks)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 4 hours

Awards & highlights

Study Summary

"This trial aims to study how naps affect memory development in infants aged 9 to 15 months. Memory is tested by observing if the child imitates a toy after seeing an experimenter interact

Who is the study for?

This trial is for infants aged 9 to 15 months to explore how napping affects their memory. Infants must be healthy with no sleep disorders like narcolepsy. They'll wear a motion-detecting watch and have electrodes on their head during naps at the study visits, which happen every three months.Check my eligibility

What is being tested?

The study tests if there's a change in how babies remember things before and after they nap. Researchers will see if the way infants imitate actions with toys changes over time, from ages 9 to 15 months, by observing them before and after morning or afternoon naps.See study design

What are the potential side effects?

There are minimal side effects expected in this study as it involves routine activities like wearing a watch and taking naps. However, some discomfort may occur from wearing the electrodes during sleep.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My child is 9 months old.

Select...

My baby was born with a normal weight and at full term.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 4 hours

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~4 hours

This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Memory accuracy

Trial Design

2Treatment groups

Experimental Treatment

Group I: Wake (non-nap)Experimental Treatment1 Intervention

Wake is promoted

Group II: NapExperimental Treatment1 Intervention

Naps are promoted

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Nap

2022

N/A

~1210

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of Maryland, College ParkOTHER

157 Previous Clinical Trials

46,015 Total Patients Enrolled

University of Massachusetts, AmherstLead Sponsor

80 Previous Clinical Trials

468,052 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are researchers currently seeking participants for this ongoing medical study?

"As per the details on clinicaltrials.gov, patient recruitment is ongoing for this particular trial. The study was first posted on September 1st, 2023 and last revised on May 1st, 2024."

Answered by AI

Which individuals meet the necessary criteria to participate in this clinical investigation?

"Individuals aged between 9 and 15 months with a confirmed diagnosis of narcolepsy are eligible to enroll in this clinical trial, which aims to recruit 100 participants."

Answered by AI

How large is the overall participant pool in this medical study?

"Indeed, the information on clinicaltrials.gov confirms that this investigation is currently enrolling subjects. The trial was initially disclosed on September 1st, 2023, and underwent its latest revision on May 1st, 2024. A total of 100 volunteers are being sought at a singular location for participation in this study."

Answered by AI